CANDOR trial design: Investigating KdD versus Kd in relapsed/refractory multiple myeloma

GMMG-CONCEPT: Isa-KRd in front-line treatment of high-risk myeloma

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer

CTC count as a prognostic marker for androgen deprivation plus orteronel or bicalutamide in mCSPC

COVID-19 and breast cancer: How should we treat our patients?

PARP inhibitors in prostate cancer: Choices of tests and how to test?

ASCO 2020: Breast cancer roundup

Perioperative novel systemic immunotherapy-based approaches in urinary cancers

TROPHIMMUN: Avelumab for gestational trophoblastic tumours resistant to monochemotherapy

Highlights from ASCO 2020

PARP inhibitors in prostate cancer: Guidelines, who to test and the patient pathway

Ensuring quality care for breast cancer patients globally